GLP-1 receptor agonist: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} | {{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} | ||
{| class="wikitable sortable" style="width:100%" | {| class="wikitable sortable" style="width:100%" | ||
|- | |- | ||
!一般名 | !一般名 |